Optogenetic
Drug screening on contractile tissue
Optogenetics enables precise, light-controlled modulation of cellular behavior and has become a powerful tool in drug development and functional screening.
Building on this approach, the myrImager is a video-optical high-throughput imaging platform developed by Universitätsmedizin Göttingen (UMG) & myriamed.
As a novel technology, it differs from SYNENTEC’s imaging devices while serving as a strong complement: it is applied across multiple areas of drug development and drug screening, resulting in significant overlap within the scientific community.
Discover all the advantages
Designed to work seamlessly with the myriamed 48-well 3D cell/tissue culture plates, the myrImager provides an advanced imaging solution for iPSC-derived tissue models used in research and drug screening aligned with ICH hERG testing guidelines.
Powered by the innovative poleDance software, the myrImager enables independent data evaluation with flexible scheduling, customisable plate layouts, and precise measurement of pole movement kinetics.
DO YOU WANT TO KNOW MORE?
We know that time is an increasingly scarce resource, even in the lab. That's why we've thought your problem through and have everything ready for a complete one-handed solution.